PCIG
ABBV icon

Partners Capital Investment Group’s AbbVie ABBV Stock Holding History

Partners Capital Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,001
Closed -$620K – 142
2023
Q4 		$620K Sell
4,001
-628
-14% -$91.6K 0.01% 165
2023
Q3 		$690K Buy
4,629
+2,756
+147% +$405K 0.02% 158
2023
Q2 		$252K Buy
+1,873
New +$275K 0.01% 195

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Partners Capital Investment Group's ABBV Position: Q1 2024 in Review

Partners Capital Investment Group sold out of AbbVie (ABBV) in Q1 2024, closing a stake of 4,001 shares — an estimated $620K sold.

Partners Capital Investment Group first reported a position in ABBV in Q2 2023 and held it in 3 quarters. The position peaked at $690K in Q3 2023. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

  • Partners Capital Investment Group reported no remaining AbbVie position as of Q1 2024 after selling out during the quarter.
  • Partners Capital Investment Group sold 4,001 AbbVie shares in Q1 2024, an estimated $620K.
  • Partners Capital Investment Group first reported a position in AbbVie in Q2 2023 and held it in 3 quarters.
  • Partners Capital Investment Group's AbbVie position peaked at $690K in Q3 2023.
  • 3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Partners Capital Investment Group's 13F filing for Q1 2024, filed 14 May 2024.